Portadas de algunos de los artículos publicados por los investigadores de innovación biomédica

Publicaciones
  • 2021
  • 2020
  • 2019

Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies
Authors: Lopez-Santalla, M. , et al
Revista y Año: EBioMedicine. 2021 Jun
DOI:  10.1016/j.ebiom.2021.103427

Enhanced Susceptibility of Galectin-1 Deficient Mice to Experimental Colitis
Authors: Fernandez-Perez, Raquel. et al
Revista y Año: Frontiers in Immunology. 2021 Jun
DOI:  10.3389/fimmu.2021.687443

CYLD Inhibits the Development of Skin Squamous Cell Tumors in Immunocompetent Mice
Authors: Josefa P. Alameda , et al
Revista y Año: Int. J. Mol. Sci. 2021 Jun
DOI:  10.3390/ijms22136736

Clinically Relevant Gene Editing in Hematopoietic Stem Cells for the Treatment of Pyruvate Kinase Deficiency
Authors: Sara Fañanas-Baquero, et al
Revista y Año: Molecular Therapy - Methods & Clinical Development 2021 May
DOI: 10.1016/j.omtm.2021.05.001

Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients

Authors: Maria José Ramírez, et al
Revista y Año: Am J Hematol 2021 May
DOI: 10.1002/ajh.26234

A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease
Authors: Vega García-Escudero, et al
Revista y Año: Acta Neuropathol 2021 May
DOI: 10.1007/s00401-021-02317-z

Functional Specificity of the Members of the Sos Family of Ras-GEF Activators: Novel Role of Sos2 in Control of Epidermal Stem Cell Homeostasis.
Authors: Baltanás FC, et al.
Revista y Año: Cancers (Basel). 2021 Apr 
DOI: 10.3390/cancers13092152

Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia.
Authors: Errazquin, R, et al.
Revista y Año: Genes 2021 Apr
DOI: 10.3390/genes12040548

Cell Therapies in Bladder Cancer Management
Authors: Lucia Morales, et al.
Revista y Año: Int J Mol Sci. 2021 Mar 
DOI: 10.3390/ijms22062818.

Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy
Authors: Iris Lodewijk, et al.
Revista y Año: Clin Epigenetics. 2021 Mar 
DOI: 10.1186/s13148-021-01046-0

Next-generation Sequencing in Bone Marrow Failure Syndromes and Isolated Cytopenias: Experience of the Spanish Network on Bone Marrow Failure Syndromes
Authors: Eva Gálvez, et al.
Revista y Año: Hemasphere, 2021 Mar 
DOI: 10.1097/HS9.0000000000000539

GSE4-loaded nanoparticles a potential therapy for lung fibrosis that enhances pneumocyte growth, reduces apoptosis and DNA damage
Authors: Pintado-Berninches L, et al.
Revista y Año: FASEB J. 2021 Mar
DOI: 10.1096/fj.202001160RR

The Current Status of Mesenchymal Stromal Cells: Controversies, Unresolved Issues and Some Promising Solutions to Improve Their Therapeutic Efficacy
Authors: García-Bernal D, et al.
Revista y Año: Front. Cell Dev. Biol.,2021 Mar
DOI: 10.3389/fcell.2021.650664

Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10
Authors: Hervás-Salcedo R, et al.
Revista y Año: Stem Cell Res Ther. 2021 Feb
DOI: 10.1186/s13287-021-02193-0

Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of DKC1
Authors: Carrascoso-Rubio C, et al.
Revista y Año: Stem Cell Res Ther. 2021 Jan
DOI: 10.1186/s13287-021-02145-8